California Public Employees Retirement System I Teos Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$17.9 - $36.1 $388,429 - $783,370	-21,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$30.86 - $44.2 $61,627 - $88,267	-1,997 Reduced 8.43%	21,700 $742,000
Q4 2020 Feb 02, 2021	SELL	$21.59 - $33.95 $10,795 - $16,975	-500 Reduced 2.07%	23,697 $801,000
Q3 2020 Nov 05, 2020	BUY	$17.57 - $32.92 $425,141 - $796,565	24,197 New	24,197 $597,000

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

Black Rock Inc. New York, NY

3.73M
Shares

$26.9 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

3.18M
Shares

$23 Million
0.45% of portfolio
Boxer Capital, LLC San Diego, CA

2.95M
Shares

$21.3 Million
1.6% of portfolio
Mpm Asset Management LLC Cambridge, MA

2.74M
Shares

$19.8 Million
19.24% of portfolio
Tang Capital Management LLC San Diego, CA

2.41M
Shares

$17.4 Million
2.09% of portfolio

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account